Peripheral stenting

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

Arterial Occlusive DiseasesArteriosclerosisAtherosclerosisVascular Diseases

Unknown Phase

Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery

CompletedNCT02921230

Boston Scientific CorporationArterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis +1

Start: 2016-10-25End: 2023-11-06Updated: 2025-02-24

A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

CompletedNCT03037411

Boston Scientific CorporationArterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis +1

Start: 2016-12-13End: 2022-03-24Updated: 2026-03-31

Related Papers

Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial

Circulation2022-10-1891 citations